Hand Foot Syndrome Secondary to Low Dose Docetaxel

Authors

  • Mutahir A Tunio Radiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh-59046, Saudi Arabia
  • Mushabbab Al Asiri Radiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh-59046, Saudi Arabia
  • Sajid Khan Durrani Medical Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh-59046, Saudi Arabia

Abstract

Hand-foot syndrome (palmoplantar erythrodysesthesia or Burgdorf reaction), is a distinctive skin toxicity affecting the palms and soles after certain chemotherapeutic drugs. Docetaxel induced hand-foot syndrome is rare, dose-dependent adverse event. Here in we report a case of Docetaxel induced grade III hand-foot syndrome at low doses (75/m2).

 Key words: Hand-foot syndrome, Docetaxel, low dose

Downloads

Additional Files

Published

2015-10-02

How to Cite

Tunio, M. A., Al Asiri, M., & Durrani, S. K. (2015). Hand Foot Syndrome Secondary to Low Dose Docetaxel. International Journal of Health Sciences, 9(3). Retrieved from https://pub.qu.edu.sa/index.php/journal/article/view/1067

Issue

Section

Case report/case series